Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP36 inhibits epithelial to mesenchymal transition. 1 / 1

| 1

➶

reach

"Our present study revealed the increased DOCK4 expression both in vivo and in vitro in circumstance of high-glucose, while knockdown of DOCK4 could reverse the overexpression of USP36 induced EMT effect, indicating a role of DOCK4 played in diabetic renal fibrosis."

33968925

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...